Skip to main content
Oncocross Co., Ltd. (KOSDAQ:382150)
South Korea flag South Korea · Delayed Price · Currency is KRW
12,790
-1,080 (-7.79%)
At close: Dec 5, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022
Period Ending
 Dec '24 Dec '23 Dec '22
Drugs
1.07B
Log In
Log In
Drugs Growth
1071.49%
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022
Period Ending
 Dec '24 Dec '23 Dec '22
South Korea
1.07B
Log In
Log In
South Korea Growth
1071.49%
Log In
Log In